Janus kinase 2 activation mechanisms revealed by analysis of suppressing mutations-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Janus kinase 2 activation mechanisms revealed by analysis of suppressing mutations

Published:2019-04 Issue:4 Volume:143 Page:1549-1559.e6
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Hammarén Henrik M.,Virtanen Anniina T.,Abraham Bobin George,Peussa Heidi,Hubbard Stevan R.,Silvennoinen Olli

Funder

Academy of Finland

Sigrid Jusélius Foundation

Jane and Aatos Erkko Foundation

Finnish Cancer Foundation

Prostate Cancer Foundation

Tampere Tuberculosis Foundation

Tampere University Hospital

National Institutes of Health

Pfizer

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference52 articles.

1. The Janus kinases (Jaks);Yamaoka;Genome Biol,2004

2. Type I/II cytokines, JAKs, and new strategies for treating autoimmune diseases;Schwartz;Nat Rev Rheumatol,2016

3. The regulation of JAKs in cytokine signaling and its breakdown in disease;Hammarén;Cytokine,2018

4. JAK inhibition as a therapeutic strategy for immune and inflammatory diseases;Schwartz;Nat Rev Drug Discov,2017

5. The Janus kinase (JAK) FERM and SH2 domains: bringing specificity to JAK–receptor interactions;Ferrao;Front Endocrinol,2017

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. JAK inhibitor selectivity: new opportunities, better drugs?;Nature Reviews Rheumatology;2024-09-09

2. The Role of the JAK–STAT Pathway in Childhood B-Cell Acute Lymphoblastic Leukemia;International Journal of Molecular Sciences;2024-06-21

3. Molecular basis of JAK2 activation in erythropoietin receptor and pathogenic JAK2 signaling;Science Advances;2024-03-08

4. High CTLA-4 gene expression is an independent good prognosis factor in breast cancer patients, especially in the HER2-enriched subtype;2024-01-31

5. Progress on the Pharmacological Targeting of Janus Pseudokinases;Journal of Medicinal Chemistry;2023-08-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3